TOTAL VOLUME:
$154.4b
24H VOL:
$235,918,089
24H TRANSACTIONS:
2,984,028,936
OPEN INTEREST:
$1,884,820,873
413,109
Markets across
40,428
events
MATCHED EVENTS:
4,364
PLATFORM COVERAGE:
5
Polymarket:
37%
VS.
Kalshi:
63%
Closed: Oct 28, 8:52 AM EST
Polymarket
As of market creation, Labcorp is estimated to release earnings on October 28, 2026. The Street consensus estimate for Labcorp’s non-GAAP EPS for the relevant quarter is $4.80 as of market creation. This market will resolve to "Yes" if Labcorp reports non-GAAP EPS greater than $4.80 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Labcorp releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Labcorp is estimated to release earnings on October 28, 2026. The Street consensus estimate for Labcorp’s non-GAAP EPS for the relevant quarter is $4.80 as of market creation. This market will resolve to "Yes" if Labcorp reports non-GAAP EPS greater than $4.80 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Labcorp releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Currently, prediction market participants are indicating a strong belief that Labcorp will beat quarterly earnings. This contrasts with typical analyst forecasts, which often present a range of possibilities and may be more conservative in their estimates. While analysts consider various financial models and company reports, this market represents the collective wisdom of individuals willing to put their capital behind their predictions. It’s important to note that prediction markets can sometimes offer a more accurate forecast than traditional polls or analyst expectations, as traders have a financial incentive to be correct.
This market resolves around Oct 28, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will be based on whether Labcorp’s reported earnings per share (EPS) exceed the consensus estimate of financial analysts covering the company. The official earnings report released by Labcorp will serve as the definitive source for determining whether the market resolves in favor of Labcorp beating earnings or not. Traders should monitor financial news sources leading up to and following the earnings release date for updates.
Several signals could significantly move this market before it resolves. Any news related to Labcorp’s performance, such as pre-earnings announcements, changes in analyst ratings, or broader economic indicators impacting the healthcare sector, could influence trading activity. Unexpected announcements from competitors or changes in regulatory policies could also play a role. Additionally, general market sentiment and risk appetite can impact trading volume and price movements. Positive news generally drives the price up, while negative news tends to push it down, reflecting shifts in traders' expectations.